Records containing: HIV
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-12-05Pilot Study: Safety and Efficacy Study of Tripterygium Wilfordii Hook F Extract in cART-Treated HIV Patients With Poor Immune Responses
-
CLINICAL_TRIALS study record update · 2013-12-04An Evaluation of Group Psychotherapy for People With HIV
-
CLINICAL_TRIALS study record update · 2013-11-27Prospective Observational Study of Male Circumcision Using the PrePex Device in Routine Clinical Settings in Kenya
-
CLINICAL_TRIALS study record update · 2013-11-15Modified Directly Observed Antiretroviral Therapy (M-DART): An Intensive, Nurse-directed, Home-centered, Treatment Strategy to Reduce Mortality and Loss to Follow-up in High-risk HIV-infected Patients Initiating Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2013-10-31A Single Arm, 3 Phase Study to Determine the Effect of Intermittent Dosing of Rifampicin on the Pharmacokinetics of Raltegravir in Healthy Volunteers
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-10-30A Randomised, Double-Blind, Placebo-Controlled, Multicentre Study In Asymptomatic Hiv-Infected Patients To Investigate The Pharmacodynamics, Pharmacokinetics, Safety And Toleration Of PF-00232798
-
CLINICAL_TRIALS study record update · 2013-10-29Effect of Selenium Supplementation on CD4 + Cell Recovery, Viral Suppression, Morbidity and Quality of Life of HIV Infected Patients in Rwanda: a Prospective, Double-Blinded, Placebo-Controlled Trial
-
CLINICAL_TRIALS study record update · 2013-10-25Prospective Assessment of Acceptability and Adherence Associated With Use of the Copper Intrauterine Device (CuT380A-IUCD) Compared to Depo-medroxyprogesterone Acetate (DMPA) Among HIV Positive Women in Lilongwe, Malawi
-
CLINICAL_TRIALS study record update · 2013-10-24A Randomized Controlled Pilot Trial Comparing Continued Antiretroviral Therapy With Tenofovir/Emtricitabine/Efavirenz (TDF/FTC/EFV) With Switch to Tenofovir/Emtricitabine/Raltegravir (TDF/FTC/RAL) on Changes in Endothelial Function and Markers of Bone Metabolism
-
CLINICAL_TRIALS study record update · 2013-10-08Phase II - Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult Male Circumcision Programs in Zimbabwe (Comparative Study)
-
CLINICAL_TRIALS study record update · 2013-09-27ClinicalTrials.gov study NCT01647841
-
CLINICAL_TRIALS study record update · 2013-09-23A Cohort Study To Assess The Impact Of A Breastfeeding Counselling And Support Strategy To Promote Exclusive Breastfeeding On Post-Natal Transmission Of HIV In African Women
-
CLINICAL_TRIALS study record update · 2013-09-19The Neurocognitive Sub Study of Encore1:A Randomised, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus 2N(t)RTI in Antiretroviral-naïve HIV-Infected Individuals Over 96 Weeks A Randomised, Double-blind, Placebo-controlled, Clinical Trial to Compare the Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals Over 96 Weeks
-
CLINICAL_TRIALS study record update · 2013-09-17Motivating HIV+ Women: Risk Reduction and ART Adherence
-
CLINICAL_TRIALS study record update · 2013-09-12Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia
-
CLINICAL_TRIALS study record update · 2013-09-12Exercise and Pioglitazone for HIV-Metabolic Syndromes
-
CLINICAL_TRIALS study record update · 2013-09-05A Non Comparative Observational Study to Describe the Duration and Outcome of Treatment in Therapy naïve HIV Positive Patients Initiated on Atazanavir (ATV)/ Ritonavir (RTV)-Based Highly Active Antiretroviral Therapy (HAART) Regimens
-
CLINICAL_TRIALS study record update · 2013-09-05The Impact of Neighborhoods, Networks, and Depression on Drug Users' HIV Risk
-
CLINICAL_TRIALS study record update · 2013-09-04A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 25 mg Once Daily Following a 2-week Period Receiving Efavirenz, in Healthy Male and Female Subjects
-
CLINICAL_TRIALS study record update · 2013-08-23Fostering an AIDS Research and Training Center Infrastructure in Russia (Labor Migrant HIV Prevention Trial)
-
CLINICAL_TRIALS study record update · 2013-08-20Using Implementation Intentions to Increase Safe Sex Practices Among and Australian Sample of Men Who Have Sex With Men
-
CLINICAL_TRIALS study record update · 2013-08-16Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults
-
CLINICAL_TRIALS study record update · 2013-08-07Phase 2/3 Clinical Trial of the Effect of a Brief Intervention on Uptake of Rapid Testing for HIV and Hepatitis C Among Emergency Department Patients
-
CLINICAL_TRIALS study record update · 2013-08-01An Open-label, Multicenter Study of Subcutaneous Intermittent Recombinant Interleukin-7 (CYT107) in Chronically HIV-infected Patients With CD4 T-lymphocyte Counts Between 101-400 Cells/mm3 and Plasma HIV RNA< 50 Copies/mL After at Least 12 Months of HAART
-
CLINICAL_TRIALS study record update · 2013-07-25A Multicenter, Open-labeled, Controlled, Randomized Study of Recombinant Interleukin-7 (CYT107) Treatment to Restore and Maintain CD4 T-lymphocyte Counts Above 500 Cells/µL in HIV-infected Patients With CD4 Counts Remaining Between 101-350 Cells/µL After at Least 2 Years of HAART and Plasma HIV RNA < 50 Copies/mL for 18 Months.